Acute leukemias of the t(4;11) (MLL-AF4 fusion gene) type frequently have high white blood counts and extramedullary disease in multiple organs. In the present study we evaluated the hypotheses that this extensive disease is the result of extramedullary survival of leukemia cells due to resistance to stressinduced cell death. Leukemias with t(4;11)(MLL-AF4) were found to be resistant to the cell death that results from serum deprivation in vitro when compared with B lineage acute leukemias without t(4;11)(MLL-AF4). Cells with t(4;11)(MLL-AF4) did not have increased doubling time or increased numbers of cells in cycle. These results suggest that the alteration in cellular homeostasis in these leukemias is due to abnormalities of cellular destruction rather than cellular proliferation when compared to other leukemias. Our results are consistent with the hypothesis that death of non-t(4;11) leukemias occurs in the microenvironment outside of the bone marrow as a result of deficient cellular and humoral growth factors. Resistance to death signals in t(4;11) leukemias results in extensive accumulation of leukemia cells in extramedullary sites and likely contributes to the poor prognosis of these leukemias.
Introduction
Acute leukemias with mixed B lymphocyte and monocyte lineage (mixed lineage leukemias) often are the result of a DNA fusion involving the MLL/HRX/ALL1 gene on chromosome 11q23 and the AF4(FEL) gene on chromosome 41q21. 1, 2 These t(4;11) leukemias are the most frequent form of ALL in infants, but also occur in older children and adults. Irrespective of age, patients with t(4;11) leukemias present with marked leucocytosis and have a poor prognosis with chemotherapy. 3, 4 The reason for the high white blood counts with a corresponding high total body burden of leukemia when compared to other acute leukemias has not been explained to date.
Total leukemia mass, including white blood count, is the result of homeostasis between cell production and cell destruction. The object of this study was to evaluate cell production and destruction rates in t(4;11) MLL-AF4 leukemia. Earlier studies from ourselves and others suggest that MLL-AF4 leukemias have relatively high cloning efficiency in culture and that long-term cell lines can be established from these leukemias. [5] [6] [7] [8] These results are consistent with the hypothesis that cells are resistant to death signals in vivo when compared to other leukemias. This study evaluated cell death in MLL-AF 4 leukemias through stress induced by serum deprivation and related this to cell production through studies of cell doubling times. 
Materials and methods

Leukemia cell lines
Established cell lines from acute lymphoblastic leukemias were used in these experiments. These cell lines were either from leukemias with t(4;11), including RS4;11 1 (previously established in our laboratory and available from American Type Culture Collection); MV4;11 6 (obtained from ATCC); B1
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(obtained from M Friedman, Sick Children's Hospital, Toronto); and AN4;11 (established in our laboratory). B lineage leukemia cell lines lacking the t(4;11) translocation were: Nalm-6 (obtained from J Minowada, Hayashibara Biochemical Lab, Okiyama, Japan); Blin-1 and 1E8 (obtained from T LeBien, University of Minnesota); and KM-3 (obtained from the ATCC). All but two cell lines were grown in RPMI-1640 tissue culture media with 10% fetal calf serum, 100 IU penicillin/ml, 100 U streptomycin/ml in 5% CO 2 . AN4;11 was grown in 20% fetal calf serum in RPMI 1640 and MV4;11 was grown in Iscove's media with L-glutamine and 25 mM Hepes buffer with 10% fetal calf serum. All tissue culture media contained 100 IU penicillin/ml and 100 U streptomycin/ml.
Viability analysis and maximal doubling times
Viability analysis and doubling times were determined by culturing cells in the appropriate optimal medium as control or submitted to cellular stress in the absence of fetal calf serum, or in the presence of dexamethasone (1 M). Data points were taken every 24 h and viability determined by counting live and dead cells by trypan blue exclusion. Maximal cell doubling times were calculated from slopes of regression lines over the 3 days of maximal growth. Doubling times were determined by obtaining the natural logarithm (to the base 2) divided by the estimated slope of the linear regression using the Excell program.
Cell cycle analysis
Cell cycle analysis was performed using a previously published method. 9 One million cells were suspended in phosphate-buffered saline and fixed with 80% ethanol overnight. Fixed cells were stained with propidium iodine (PI). Staining solution was 50 g/ml of PI and 100 U/ml of RNase in PBS. The PI stained samples were analyzed by FACSCalibur (Becton Dickinson, Mountain View, CA, USA) within 24 h. The percentage of S phase cells on day 2 of growth was calculated by the FACSCalibur computer program. 
Statistical analysis
Data analysis was conducted using comparisons of means and standard error of means using a standard statistical package.
Results
Acute leukemias with MLL-AF4 abnormality have prolonged doubling times with low percentage of cells in cycle
Studies were carried out in which doubling times were compared in MLL-AF4 leukemias to leukemias without the MLL-AF4 abnormality. Doubling times results are the means of three to seven experiments and are shown in Table 1 . These results demonstrate that MLL-AF4 leukemias had doubling times which ranged from 1.3 ± 0.16 to 2.2 ± 0.17 days with a mean of 1.7 ± 0.08 days. In contrast, the non MLL-AF4 leukemias had doubling times which ranged from 0.9 ± 0.05 to 1.4 ± 0.08 days with a mean of 1.1 ± 0.04 days. This difference was statistically significant (P Ͻ 0.001). Also shown in Table 1 are results evaluating cell cycle in the same cell lines. Percentages of cells in S phase of the cell cycle ranged from 23.8 ± 3.4 to 34.7 ± 3.4% in MLL-AF4 leukemias compared to non-MLL-AF4 leukemias in which cells in S phase ranged from 40.8 ± 5.9 to 53.9 ± 0.1%. The mean for the t(4;11) group was 28.7 ± 1.8% and 47 ± 2.0% for the non-t(4;11) group. This difference was statistically significant (P Ͻ 0.001). The differences between t(4;11) and nont(4;11) leukemias in S phase percentages are shown graphically in Figure 1 . The shaded areas represent cells in S phase and compare MLL-AF4 leukemia (AN4;11) in panel a and a non-MLL-AF4 leukemia (Blin1) in panel b. In summary, t(4;11)(MLL-AF4) leukemias had statistically significantly prolonged doubling times and fewer cells in S phase when compared to non-t(4;11)(MLL-AF4) leukemias.
Cells from MLL-AF4 leukemias are resistant to serum deprivation-induced cell death compared to other B lineage leukemias
A series of experiments were conducted to evaluate the effect of serum deprivation. As a measure of cellular ability to resist the stresses associated with deprivation from critical growth factors, serum deprivation is known to induce cell death in a wide variety of cell types. We postulated that serum deprivation stress is likely to be somewhat similar to the stresses of the extra-marrow environment as the normal home of the lymphoid progenitors is within the bone marrow. In these experiments, MLL-AF4 cells were compared with cells of similar phenotype but lacking the MLL-AF4 t(4;11) translocation. Results of representative experiments are shown in Figure 2 . Cells were grown in the presence or absence of serum for 1-3 days. Cell viability was defined as the ratio of viable cells compared to the total cell population. MLL-AF4 cell viability is shown in panels a, c, e and non-MLL-AF4 cells in panels b, d and f. Non-MLL-AF4 cells in panels b, d, f in the absence of serum (closed triangles), displayed dramatic reduction in viability at days 1, 2 and 3; viability was always less than 0.15 at 3 days. By contrast, the viability of MLL-AF4 cells in panels Comparison of t(4;11) and non-t(4;11) leukemias cell lines grown in stressed conditions. x-axis, days in culture; y-axis, ratio of viable cells to total cells. (ȣ-ȣ) Optimal growth conditions; (̆-̆) growth in absence of serum. t(4;11) lines in (a) (RS4;11) (c) (AN4;11) and panel e (B1). Non-t(4;11) lines in (b) (Nalm-6), (d) (Blin-1) and (f) (1E8). a, c and e, although less than cells grown in the presence of serum, remained relatively high and at the end of 3 days dropped no lower than 0.55.
MLL-AF4 leukemia resistance to serum deprivationinduced cell death is not the result of soluble growth production factors by leukemia cells
The resistance of MLL-AF4 t(4;11) leukemia cells to serum deprivation-induced cell death may be the result of the fact that the cells may secrete a factor(s) that allows them to survive starvation. In order to determine if there was a factor(s) involved, t(4;11) cells and non-t(4;11) cells were grown in 0% FBS-RPMI media. The media were collected after 3 days of growth. Ph-adjusted conditioned media were used in subsequent experiments to grow t(4;11) cells and non-t(4;11) cells. The conditioned media from MLL-AF4 t(4;11) cells did not prevent serum starvation-induced death when used in subsequent cultures with MLL-AF4 or non-MLL-AF4 cells (data not shown). These results provide no support for the hypothesis that MLL-AF4 cells provide soluble growth factor(s) that prevent serum starvation-induced cell death.
Discussion
The present study was designed to evaluate the biology of the t(4;11) leukemias which result from the development of a fusion between the 5Ј portion of the (MLL/HRX/ALL1) gene and the 3Ј portion of the AF4/FEL gene. Leukemia cells are known to be present in the blood and other organs at the time of diagnosis, and as a result, patients generally have a large leukemia burden. The reasons for this large leukemia mass have never been fully explained and were the aim of this study. The totality of the leukemia mass is the net result of cells produced but not destroyed; both production and destruction were evaluated in this study.
The doubling times of MLL-AF4 cell lines demonstrated that the half lives were not shortened and, in fact, in most cases longer than non-MLL-AF4 leukemias. These often prolonged doubling times were consistent with the observation that the MLL-AF4 leukemia cells were found to have a relatively high percentage of cells in the G0 and G1 phase of the cell cycle and a low percentage of cells in S phase compared to non-MLL-AF4 leukemia cells. These results suggest that the leukocytocis and high level of tumor seen in t(4;11) MLL-AF4 leukemias, when compared to other leukemias, is not due to a more rapid doubling time or more rapid rate of cell proliferation.
Previous studies from our group and others demonstrate that cells from t(4;11) leukemias differ from most other forms of acute lymphoblastic leukemia in that cells are more easily grown in short-term culture; the establishment of these long-term cell lines is more probable than with other leukemias. [5] [6] [7] [8] The significance of these earlier observations demonstrating the growth factor independence of MLL-AF4 leukemias has not been clear to date. This independence could be the result of resistance to cell death, which is known to be induced in hematopoietic cells lines under stress conditions induced by withdrawal of critical growth factors. 10 Our results are consistent with the hypothesis that the t(4;11) cells have a relatively long life in vivo because of their resistance to stressful (growth factor deprived) conditions which are likely to exist outside the site of normal precursor development in bone marrow. This prolonged survival may account for the large leukemia burden, including the high white counts with which these patients present clinically. The present study could not determine whether the observed effects are direct effects of the MLL-AF4 fusion gene product, or other genetic alterations present in these cells.
The mechanisms of cell death were not delineated in this study. The results as presented do not distinguish cell death from an active apoptotic cell death pathway from cell death due to necrosis. Additional experiments will be necessary to evaluate these two possibilities. Study results were entirely with cell lines that have been established in long-term culture and therefore might have additional genetic changes and/or undergone selection through the culture process. Confirmation of the study results using leukemia cells freshly isolated from patients and cells that have been transfected with the MLL-AF4 fusion genes will be important.
